BrightWater Medical

BrightWater Medical

Medical devices that focus on treatments for ureteral blockages by interventional radiologists. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
CAD48m (Public information from Jun 2019)
Mountain View California (HQ)
  • Edit
DateInvestorsAmountRound

$5.2m

Series A

$35.0m

Valuation: $35.0m

Acquisition
Total FundingCAD7.1m

Recent News about BrightWater Medical

Edit
More about BrightWater Medicalinfo icon
Edit

BrightWater Medical specializes in developing advanced medical devices for treating severe ureteral and biliary obstructions. Their flagship product, the ConvertX Stent Family, is unique in that it can convert to an internal stent without requiring a second interventional procedure, significantly reducing patient risk and healthcare costs. The ConvertX Biliary System is also the first to offer a percutaneous plastic biliary stent option, providing interventional radiologists with a new tool for patient care.

The company primarily serves healthcare providers, including urologists and interventional radiologists, operating in the medical device market. BrightWater Medical's business model revolves around the sale of its proprietary stent systems to hospitals and clinics, generating revenue through direct sales and partnerships.

Keywords: ureteral obstruction, biliary obstruction, ConvertX Stent, medical devices, interventional radiology, urology, healthcare innovation, patient care, cost reduction, proprietary technology.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.